Systematic Review and Meta-analysis of Group B Streptococcus Rectovaginal Colonization Rates and Serotype Distribution among Pregnant Women, Asia-Pacific Region, 2014-2025.

Emerg Infect DisOct 1, 2026
Clinical ResearchObstetrics & Gynecology

Zheng Quan Toh, Lien Anh Ha Do, Darren Suryawijaya Ong et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review and meta-analysis examined group B Streptococcus (GBS) rectovaginal colonization rates among 978,150 pregnant women in the Asia-Pacific region. The study found a pooled prevalence of 18.0% (95% CI 12%-23%) for GBS colonization. A total of 98 studies were included in the analysis, highlighting the need for ongoing surveillance in this population.

Key findings

  • The pooled estimated prevalence of GBS colonization was 18.0% (95% CI 12%-23%).
  • Serotype III was the most common GBS serotype, with a range of 5.0%-100.0%.
  • Low antimicrobial drug resistance rates (0%-2.0%) were found for β-lactams.

Why it matters

Understanding GBS colonization rates and serotype distribution is crucial for developing effective prevention and treatment strategies in pregnant women, particularly in regions with limited data.

Source

Published in Emerg Infect Dis. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Obstetrics & Gynecology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.